Skip to main content
← Back to sources

Pharmaphorum January 2026 Trends Report Highlights AI-Designed Therapeutics, Genomic Scale, and Operational AI Adoption in Life Sciences

Published 2026-02-01Ingested 2026-03-01Enterprise AI DeliveryMedium

Summary

Pharmaphorum's January 2026 industry trends report identifies three major AI-driven shifts in the life sciences sector. First, Basecamp Research's EDEN evolutionary models and aiPGI platform are being used to design therapeutic enzymes and antimicrobial peptides with high laboratory validation rates, marking a transition from in silico screening to AI as a direct creator of biological therapeutics. Second, SOPHiA GENETICS surpassed 2 million genomic profiles analyzed on its DDM platform and esta

Alignment: Reinforces current position
Related Positions: enterprise-ai-delivery.md, ai-infrastructure-strategy.md
life-sciences-aidrug-designgenomicsdigital-twinsoperational-aisupply-chainenterprise-ai-adoptionpharmaai-therapeutics
Pharmaphorum January 2026 Trends Report Highlights AI-Designed Therapeutics, Genomic Scale, and Operational AI Adoption in Life Sciences — Intelligence — Agentic Developer Tools Radar · Signal